iBio Selects Lead Candidate for its Fibrosis Therapeutics Program
March 14, 2018 08:30 ET
|
iBio, Inc.
NEW YORK, March 14, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio”) announced today that it had selected an E4-Fc fusion protein as its lead candidate for further development of a...
iBio Patent Issues in China on Protein Glycosylation Modification
March 12, 2018 08:30 ET
|
iBio, Inc.
NEW YORK, March 12, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN:IBIO) (“iBio”) announced the expansion of its intellectual property portfolio with the issuance of a patent in China describing...
iBio Expands Antibody Development and Production Services to Include Fc Fusion Therapeutics
March 07, 2018 08:45 ET
|
iBio, Inc.
NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN:IBIO) (“iBio”) announced the expansion of its CDMO capabilities and services to include the development and cGMP manufacturing...
iBio, Inc. Provides Corporate Update
January 05, 2018 17:00 ET
|
iBio, Inc.
NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN:IBIO) (“IBIO” OR THE “COMPANY”) announced today its receipt of notice that Staff of NYSE American LLC determined that the...
iBio, Inc. Closes $4,500,000 Offering of Common Stock
November 30, 2017 16:15 ET
|
iBio, Inc.
NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN:IBIO) (“IBIO” OR THE “COMPANY”), today announced the closing of its previously announced public offering of 22,500,000 shares of...
iBio, Inc. Prices $4,500,000 Firm Commitment Offering of Common Stock
November 29, 2017 09:00 ET
|
iBio, Inc.
NEW YORK, Nov. 29, 2017 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN:IBIO) (“IBIO” OR THE “COMPANY”), today announced the pricing of a firm commitment public offering of 22,500,000 shares of its...
iBio, Inc. Announces Proposed Public Offering of Common Stock
November 28, 2017 17:07 ET
|
iBio, Inc.
NEW YORK, Nov. 28, 2017 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN:IBIO) (“IBIO” OR THE “COMPANY”) announced today that it intends to launch an offering of shares of its common stock for sale in...
iBio, Inc. Initiates Litigation Against Fraunhofer-Gesellschaft in Delaware Chancery Court
November 06, 2017 17:00 ET
|
iBio, Inc.
NEW YORK, Nov. 06, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced today...
iBio CDMO President to Co-Chair South African Molecular Pharming Conference
October 30, 2017 08:30 ET
|
iBio, Inc.
NEW YORK, Oct. 30, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced that Dr....
iBio Announces Manufacturing Collaboration with Aethlon Medical
October 16, 2017 07:15 ET
|
iBio, Inc.
NEW YORK, Oct. 16, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced the...